• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿毒症毒素与人血清白蛋白结合位点的表征

Characterization of binding site of uremic toxins on human serum albumin.

作者信息

Sakai T, Takadate A, Otagiri M

机构信息

Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.

出版信息

Biol Pharm Bull. 1995 Dec;18(12):1755-61. doi: 10.1248/bpb.18.1755.

DOI:10.1248/bpb.18.1755
PMID:8787801
Abstract

The interaction of uremic toxins including indole-3-acetic acid (IA), indoxyl sulfate (IS), hippuric acid (HA) and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) with human serum albumin (HSA) has been investigated by three methods of fluorescent probe displacement, ultrafiltration and equilibrium dialysis. The binding parameter of CMPF was found to have the strongest affinity (10(7)M-1) among all the uremic toxins studied. Competitive experiment based on the method of Kragh-Hansen suggested that IA, IS and HA bind to site II, whereas CMPF binds to site I. The present limited data indicated that the four uremic toxins caused inhibition to any endo- or exogenous substances on HSA.

摘要

通过荧光探针置换、超滤和平衡透析三种方法,研究了包括吲哚 - 3 - 乙酸(IA)、硫酸吲哚酚(IS)、马尿酸(HA)和3 - 羧基 - 4 - 甲基 - 5 - 丙基 - 2 - 呋喃丙酸(CMPF)在内的尿毒症毒素与人血清白蛋白(HSA)的相互作用。在所有研究的尿毒症毒素中,发现CMPF的结合参数具有最强的亲和力(10⁷M⁻¹)。基于Kragh - Hansen方法的竞争性实验表明,IA、IS和HA结合到位点II,而CMPF结合到位点I。目前有限的数据表明,这四种尿毒症毒素对HSA上的任何内源性或外源性物质都有抑制作用。

相似文献

1
Characterization of binding site of uremic toxins on human serum albumin.尿毒症毒素与人血清白蛋白结合位点的表征
Biol Pharm Bull. 1995 Dec;18(12):1755-61. doi: 10.1248/bpb.18.1755.
2
Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serum.尿毒症血清中阴离子药物对与白蛋白结合的内源性配体的置换作用。
Ther Drug Monit. 1988;10(3):261-4. doi: 10.1097/00007691-198803000-00003.
3
Interaction between two dicarboxylate endogenous substances, bilirubin and an uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid, on human serum albumin.两种二羧酸内源性物质,胆红素和一种尿毒症毒素3-羧基-4-甲基-5-丙基-2-呋喃丙酸,对人血清白蛋白的相互作用。
Pharm Res. 1999 Jun;16(6):916-23. doi: 10.1023/a:1018842506896.
4
Exploring binding characteristics and the related competition of different protein-bound uremic toxins.探索不同蛋白结合型尿毒症毒素的结合特性及相关竞争性。
Biochimie. 2017 Aug;139:20-26. doi: 10.1016/j.biochi.2017.05.010. Epub 2017 May 17.
5
A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia.呋喃脂肪酸和硫酸吲哚酚被认为是尿毒症中甲状腺素肝细胞转运的抑制剂。
J Clin Endocrinol Metab. 1993 Feb;76(2):318-24. doi: 10.1210/jcem.76.2.8432774.
6
Influences of haemodialysis on the binding sites of human serum albumin: possibility of an efficacious administration plan using binding inhibition.血液透析对人血清白蛋白结合位点的影响:基于结合抑制制定有效给药方案的可能性
Nephrol Dial Transplant. 2008 Jul;23(7):2304-10. doi: 10.1093/ndt/gfn002. Epub 2008 Apr 5.
7
Decreased bilirubin-binding capacity in uremic serum caused by an accumulation of furan dicarboxylic acid.呋喃二羧酸的积累导致尿毒症血清中胆红素结合能力下降。
Nephron. 2000 May;85(1):60-4. doi: 10.1159/000045631.
8
In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.使用电位离子探针技术对双氯芬酸和尿毒症毒素与血清白蛋白及人血浆的竞争性结合进行的体外研究。
J Pharm Pharmacol. 2006 Nov;58(11):1467-74. doi: 10.1211/jpp.58.11.0007.
9
Protein-bound uremic retention solutes.蛋白结合型尿毒症潴留溶质
Adv Ren Replace Ther. 2003 Oct;10(4):310-20. doi: 10.1053/j.arrt.2003.08.002.
10
A major inhibitor of phenytoin binding to serum protein in uremia.尿毒症中苯妥英与血清蛋白结合的主要抑制剂。
Nephron. 1988;48(4):310-4. doi: 10.1159/000184949.

引用本文的文献

1
Loop diuretics in anuric hemodialysis patients for the clearance of protein-bound uremic toxins.在无尿血液透析患者中使用袢利尿剂清除蛋白结合型尿毒症毒素。
Clin Kidney J. 2025 Jun 14;18(7):sfaf195. doi: 10.1093/ckj/sfaf195. eCollection 2025 Jul.
2
Transporter-Mediated Interactions Between Uremic Toxins and Drugs: A Hidden Driver of Toxicity in Chronic Kidney Disease.尿毒症毒素与药物之间的转运体介导相互作用:慢性肾脏病中毒性的一个隐藏驱动因素
Int J Mol Sci. 2025 Jun 30;26(13):6328. doi: 10.3390/ijms26136328.
3
Tangential flow filtration facilitated fractionation of polymerized human serum albumin: Insights into the effects of molecular size on biophysical properties.
切向流过滤促进聚合人血清白蛋白的分级分离:分子大小对生物物理性质影响的见解。
Biotechnol Prog. 2024 Nov-Dec;40(6):e3500. doi: 10.1002/btpr.3500. Epub 2024 Jul 29.
4
Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease.转移负担:慢性肾脏病中蛋白结合尿毒症毒素清除策略综述
J Clin Med. 2024 Mar 1;13(5):1428. doi: 10.3390/jcm13051428.
5
Detailing Protein-Bound Uremic Toxin Interaction Mechanisms with Human Serum Albumin in the Pursuit of Designing Competitive Binders.解析蛋白结合尿毒症毒素与人体血清白蛋白相互作用机制,设计竞争结合物。
Int J Mol Sci. 2023 Apr 18;24(8):7452. doi: 10.3390/ijms24087452.
6
The Piezo1 hypothesis of renal anemia.肾性贫血的Piezo1假说。
FASEB Bioadv. 2022 May 25;4(7):436-440. doi: 10.1096/fba.2022-00024. eCollection 2022 Jul.
7
The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction.尿毒症毒素与白蛋白、膜转运体的相互作用及药物相互作用。
Toxins (Basel). 2022 Feb 26;14(3):177. doi: 10.3390/toxins14030177.
8
Interaction of Human Serum Albumin with Uremic Toxins: The Need of New Strategies Aiming at Uremic Toxins Removal.人血清白蛋白与尿毒症毒素的相互作用:针对尿毒症毒素清除的新策略需求
Membranes (Basel). 2022 Feb 25;12(3):261. doi: 10.3390/membranes12030261.
9
Molecular Probes, Chemosensors, and Nanosensors for Optical Detection of Biorelevant Molecules and Ions in Aqueous Media and Biofluids.用于在水相介质和生物流体中光学检测生物相关分子和离子的分子探针、化学传感器和纳米传感器。
Chem Rev. 2022 Feb 9;122(3):3459-3636. doi: 10.1021/acs.chemrev.1c00746. Epub 2022 Jan 7.
10
Indoxyl Sulfate Contributes to mTORC1-Induced Renal Fibrosis via The OAT/NADPH Oxidase/ROS Pathway.硫酸吲哚酚通过 OAT/NADPH 氧化酶/ROS 途径促进 mTORC1 诱导的肾纤维化。
Toxins (Basel). 2021 Dec 18;13(12):909. doi: 10.3390/toxins13120909.